KY19334 is a CXXC5-DVL inhibitor. KY19334 can activate the Wnt/beta-catenin pathway by inhibiting CXXC5-Dvl interaction. KY19334 can inhibit cancer cells proliferation, migration, invasion and transformation by inhibiting CDK1. KY19334 can accelerate wound healing and exert regenerative effects. KY19334 can be used for the researches of cancer, inflammation, metabolic and neurological disease, such as cutaneous squamous cell carcinoma and diabetes[1].
Molecular Weight:
307.30
CAS Number:
[2319609-67-9]
Formula:
C17H13N3O3
Target:
CDK,Wnt,beta-catenin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
